A rational pharmacologic approach toward a biologically meaningful subtype of autism spectrum disorder
- PMID: 32473111
- PMCID: PMC9432312
- DOI: 10.1016/j.jped.2020.05.001
A rational pharmacologic approach toward a biologically meaningful subtype of autism spectrum disorder
Comment on
-
Effect of prednisolone on language function in children with autistic spectrum disorder: a randomized clinical trial.J Pediatr (Rio J). 2021 Jan-Feb;97(1):22-29. doi: 10.1016/j.jped.2019.10.012. Epub 2020 Apr 22. J Pediatr (Rio J). 2021. PMID: 32330433 Free PMC article. Clinical Trial.
References
-
- Thom R.P., Keary C.J., Palumbo M.L., Ravichandran C.T., Mullett J.E., Hazen E.P., et al. Beyond the brain: a multi-system inflammatory subtype of autism spectrum disorder. Psychopharmacology (Berl) 2019;236:3045–3061. - PubMed
-
- McDougle C.J., Landino S.M., Vahabzadeh A., O’Rourke J., Zurcher N.R., Finger B.C., et al. Toward an immune-mediated subtype of autism spectrum disorder. Brain Res. 2015;1617:72–92. - PubMed
-
- Depino A.M. Peripheral and central inflammation in autism spectrum disorders. Mol Cell Neurosci. 2013;53:69–76. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical